Triclosen and Its Alternatives in Antibacterial Soaps.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In 2017, the Food and Drug Administration banned the marketing of triclosan and triclocarban in antibacterial soaps, citing inefficacy and concerns of systemic absorption and antibacterial resistance. As a result, there is an anticipated decrease in the number of triclosan-containing products on the market with an associated increase in antibacterial alternatives (eg, benzalkonium chloride, benzethonium chloride, chloroxylenol, chlorhexidine) and cases of allergic and irritant contact dermatitis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Dermatitis

Title: Dermatitis : contact, atopic, occupational, drug

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 2162-5220

ISSN (Print): 1710-3568

Publication date (Electronic): November 7 2019

Volume: 30

Issue: 6

Affiliations

[1 ] From the Department of Dermatology, University of Colorado, Aurora.

[2 ] School of Medicine, University of Colorado, Aurora.

[3 ] School of Medicine, Rocky Vista University, Parker.

[4 ] Rocky Mountain Regional Veteran Affairs Medical Center, Aurora, CO.

Article

DOI: 10.1097/DER.0000000000000519

PubMed ID: 31688130

SO-VID: 6930ce65-bcea-4412-afc4-2b0976bde024

History

Data availability:

Comments

Comment on this article

scite_

Cited by 4

See all cited by